DOMAGROZUMAB
UNII 516MD5WQ24

Substance Identification & Data

This profile provides standardized clinical and technical data for Domagrozumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 516MD5WQ24.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1629605-31-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
516MD5WQ24
CAS Registry Number
1629605-31-7
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
DOMAGROZUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C166800
National Cancer Institute reference terminology for clinical and research data.
INN ID
10286
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
CD-64
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Domagrozumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

DOMAGROZUMAB

Common Names & Synonyms

DOMAGROZUMAB [INN]
DOMAGROZUMAB [JAN]
DOMAGROZUMAB [USAN]
DOMAGROZUMAB [WHO-DD]
IMMUNOGLOBULIN G1, ANTI-(HUMAN-MUS MUSCULUS GROWTH DIFFERENTIATION FACTOR 8) (HUMAN-MUS MUSEU/US MONOCLONAL PF-06252616 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL PF-06252616 LIGHT CHAIN, DIMER

Technical Codes

PF-06252616

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus